Lovisa Wennstrom
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia.
Journal: Nature
Published: February 28, 2025
Histamine dihydrochloride and low-dose interleukin-2 in an emerging landscape of relapse prevention in acute myeloid leukemia.
Journal: Therapeutic advances in hematology
Published: January 24, 2025
Consistency of the efficacy of immunotherapy with histamine dihydrochloride and low-dose interleukin-2 for relapse prevention in acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: December 24, 2024
Single-cell proteo-transcriptomic profiling reveals altered characteristics of stem and progenitor cells in patients receiving cytoreductive hydroxyurea in early-phase chronic myeloid leukemia.
Journal: Haematologica
Published: January 15, 2024
Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia.
Journal: Frontiers in immunology
Published: December 25, 2021
Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia.
Journal: Frontiers in immunology
Published: October 15, 2021
A risk score based on real-world data to predict early death in acute promyelocytic leukemia.
Journal: Haematologica
Published: September 29, 2021
Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study.
Journal: Leukemia & lymphoma
Published: March 15, 2021
Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry.
Journal: British journal of haematology
Published: November 30, 2020
Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
Journal: Genes, chromosomes & cancer
Published: November 24, 2020
Last Updated: 09/26/2026